BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 7.12

Change

-0.01 (-0.14)%

Market Cap

USD 2.53B

Volume

2.28M

Analyst Target

USD 26.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 80.66B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 42.46B
HLN Haleon plc

N/A

USD 39.18B
TEVA Teva Pharma Industries Ltd ADR

N/A

USD 19.18B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 11.67B
CTLT Catalent Inc

N/A

USD 10.02B
ELAN Elanco Animal Health

N/A

USD 9.03B
PRGO Perrigo Company PLC

N/A

USD 3.75B
EVT Eaton Vance Tax Advantaged Div..

N/A

USD 3.26B
PBH Prestige Brand Holdings Inc

N/A

USD 3.21B

ETFs Containing BHC

ITA 13.40 % 0.42 %

N/A

N/A
MJJ 9.90 % 0.00 %

N/A

N/A
MJO 9.90 % 0.00 %

N/A

N/A
PPA Invesco Aerospace & Defen.. 6.29 % 0.59 %

N/A

USD 3.35B
HHL:CA Harvest Healthcare Leader.. 5.03 % 1.15 %

N/A

CAD 0.33B
FMK 4.35 % 0.70 %

N/A

N/A
EDOC Global X Telemedicine & D.. 4.25 % 0.00 %

N/A

USD 0.05B
GNOM Global X Genomics & Biote.. 4.14 % 0.00 %

N/A

USD 0.10B
BUZ 3.50 % 0.75 %

N/A

N/A
XLI Industrial Select Sector .. 2.82 % 0.13 %

N/A

USD 18.54B
UXI ProShares Ultra Industria.. 1.93 % 0.95 %

N/A

USD 0.02B
DRDR:LSE iShares Healthcare Innova.. 1.79 % 0.00 %

N/A

USD 1.06B
HEAL:LSE iShares Healthcare Innova.. 1.69 % 0.00 %

N/A

USD 1.06B
OEW 1.25 % 0.40 %

N/A

N/A
NHYB:CA NBI High Yield Bond ETF 0.89 % 0.00 %

N/A

CAD 1.07B
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.86 % 0.00 %

N/A

USD 0.14B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.84 % 0.00 %

N/A

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.84 % 0.00 %

N/A

USD 0.13B
SJNK:SW SPDR® Bloomberg SASB U.S.. 0.84 % 0.00 %

N/A

USD 0.14B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.74 % 0.00 %

N/A

USD 0.14B
BSJL 0.00 % 0.41 %

N/A

N/A
CJNK 0.00 % 0.30 %

N/A

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

N/A

USD 16.73B
IYJ 0.00 % 0.42 %

N/A

N/A
RFUN 0.00 % 0.51 %

N/A

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

N/A

USD 0.11B
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

N/A

CAD 0.05B
HYGV FlexShares® High Yield V.. 0.00 % 0.37 %

N/A

USD 1.39B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.00 %

N/A

USD 0.13B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

N/A

USD 0.09B
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

N/A

USD 2.25B
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

N/A

USD 3.28B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

N/A

USD 0.93B
SYBJ:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.52B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

N/A

USD 0.09B
FSYD Fidelity Sustainable High.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.22% 25% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.22% 25% F 11% F
Trailing 12 Months  
Capital Gain 18.27% 56% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.27% 56% F 58% F
Trailing 5 Years  
Capital Gain -71.79% 15% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.79% 15% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain -6.97% 44% F 14% F
Dividend Return -6.97% 44% F 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.91% 38% F 19% F
Risk Adjusted Return -13.69% 50% F 19% F
Market Capitalization 2.53B 38% F 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector